Skip to main content
    E

    Entero Therapeutics, Inc. (ENTO)

    Official site

    BIOTECHNOLOGY

    $4.25
    -0.30 (-6.59%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    31%(8/26)
    Avg Surprise
    -25.34%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 20
    		$-0.75N/AN/ABeat-28.5%
    Jun 25
    Reported Aug 14
    		$-0.48N/AN/ABeat+95.2%
    Mar 25
    Reported Apr 4
    		$-0.28$0.00N/ABeat-174.1%
    Dec 24
    Reported Mar 27
    		$-2.59N/AN/ABeat+51.5%
    Sep 24
    Reported Nov 13
    		$-0.59$-0.32-83.00%Miss+93.6%
    Jun 24
    Reported Aug 26
    		$-10.10$-4.65-117.19%Miss+73.3%
    Mar 24
    Reported May 14
    		$0.38N/A+115.64%Beat+100.3%
    Dec 23
    Reported Feb 27
    		$-5.35$-4.03-32.75%Miss+3.6%
    Sep 23
    Reported Nov 13
    		$-9.20$-12.30+25.20%Beat-453.8%
    Jun 23
    Reported Aug 14
    		$-37.80$-20.80-81.73%Miss-404.0%
    Mar 23
    Reported Jun 29
    		$-109.39N/AN/ABeat-16474.3%
    Dec 22
    Reported Mar 1
    		$-5.55N/A+90.45%Beat-262.7%
    Sep 22
    Reported Nov 23
    		$2.60$-3.01+186.38%Beat+179.5%
    Jun 22
    Reported Aug 15
    		$-7.50$-15.00+50.00%Beat-368.8%
    Mar 22
    Reported May 23
    		$-0.66$-0.35-85.92%Miss-371.4%
    Dec 21
    Reported Mar 2
    		$-1.53$-0.76-102.19%Miss-155.0%
    Sep 21
    Reported Nov 11
    		$-3.27$-2.05-59.51%Miss-595.7%
    Jun 21
    Reported Aug 10
    		$-1.60$-1.47-8.84%Miss-841.2%
    Mar 21
    Reported Jun 2
    		$-0.14$-0.09-55.56%Miss+30.0%
    Dec 20
    Reported Mar 3
    		$-0.60$-0.13-352.83%Miss-1100.0%
    Sep 20
    Reported Nov 12
    		$-0.47$-0.27-76.23%Miss-176.5%
    Jun 20
    Reported Aug 11
    		$-0.17$-0.17+0.00%Beat+32.0%
    Mar 20
    Reported Jun 3
    		$-0.20$-0.16-25.00%Miss+23.1%
    Dec 19
    Reported Feb 26
    		$-0.05N/A+68.75%Beat+78.3%
    Sep 19
    Reported Dec 27
    		$-0.17$-0.16-6.25%Miss+22.7%
    Jun 19
    Reported Aug 13
    		$-0.25$-0.22-13.64%Miss-13.6%
    Mar 19
    Reported May 29
    		$-0.26$-0.25-4.00%Miss+10.3%
    Dec 18
    Reported Feb 27
    		$-0.23$-0.18-27.78%Miss+100.0%
    Sep 18
    Reported Nov 26
    		$-0.22$-0.20-10.00%Miss+100.0%
    Jun 18
    Reported Aug 29
    		$-0.22$-0.24+8.33%Beat+100.0%
    Mar 18
    Reported May 30
    		$-0.29$-0.18-61.11%Miss+100.0%
    Dec 17
    Reported Mar 30
    		$-26341.74N/AN/ABeat-
    Sep 17
    Reported Nov 29
    		$-35126.35N/AN/ABeat-
    Jun 17
    Reported Aug 30
    		$-33448.00N/AN/ABeat-
    Mar 17
    Reported Jun 29
    		$-36753.91N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.16xQuick Ratio0.16x
    Trading Statistics
    BetaN/AAvg Volume88.55K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.26
    SMA 20$3.88
    SMA 50$3.60
    SMA 200$3.47
    EMA 10$4.28
    EMA 20$4.01
    EMA 50$3.77
    EMA 200$3.48

    MACD

    Line: 0.30Signal: 0.22Hist: 0.08

    ADX

    ADX: 23.8+DI: 26.7-DI: 12.0

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down12.0
    PSAR$3.99

    Bollinger Bands

    Upper Band$4.99
    Lower Band$2.76
    %B Position5766%(Upper)
    Band Width0.67

    RSI (14-Day)

    Neutral
    56.0

    Momentum Oscillators

    Stoch %K70.6
    Stoch %D81.4
    Williams %R-42.0
    ROC (10d)15.4%
    Momentum0.57
    CCI (20d)91.9
    MFI (14d)69.4

    Volatility Measures

    ATR (14d)$0.46(10.9%)
    StdDev (20d)0.56
    Hist Vol122.9%(High)

    Volume Flow

    VWAP$4.49
    OBV389.2M
    AD Line4.2B
    CMF (20d)0.070

    Volume Metrics

    Avg Vol (20d)92.4K
    Vol Ratio0.7x
    VWMA (20d)$3.92

    Pivot Points

    R3$5.03
    R2$4.86
    R1$4.70
    Pivot Point$4.53
    S1$4.37
    S2$4.20
    S3$4.04

    Advanced Oscillators

    TSI20.84
    Ultimate Osc48.3
    KST231.97

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$38,208$36,251$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$651,948$693,683$0$0$0N/A$0$0$0$7,319$0$0
    Gross Profit$-613,740$-657,432$0$0$0N/A$0$0$0$-7,319$0$0
    Operating Expenses$3.00M$4.03M$934,787$638,864$821,386$1.20M$1.89M$3.43M$9.10M$4.09M$3.43M$4.18M
    R&D$631,380$892,351$6,673$10,631$15,827$-77,311$206,999$219,591$554,662$1.31M$1.01M$1.35M
    SG&A$2.37M$3.14M$928,114$628,233$805,559$1.28M$1.69M$3.21M$8.54M$2.79M$2.42M$2.83M
    Operating Income$-3,614,498$-4,688,401$-934,787$-638,864$-821,386$-1,203,511$-1,892,607$-3,426,108$-9,099,048$-4,093,621$-3,433,137$-4,181,644
    Interest Income$-522,100$-418,699$-36,069$-36,067$-17,902$200$229$218$228$0$0$0
    Interest Expense$121,832$0$36,069$36,067$126,719$0$2,645$4,114$0$7,319$1,021$4,973
    Income Before Tax$-3,736,330$-4,046,124$-970,856$-674,931$-948,105$-1,194,074$-1,895,252$-3,430,222$-9,099,473$-4,100,940$-3,434,158$-4,189,232
    Income Tax Expense$-297,629$-398,736$0$0$0$10.60M$0$4.26M$-14,859,887$0$0$0
    Net Income$-3,438,702$-3,142,878$-1,152,809$-998,271$-1,259,620$-12,238,269$-2,580,971$-8,807,702$5.57M$-4,100,940$-3,434,158$-4,189,232
    EBITDA$-2,303,248$-2,704,359$-934,787$-638,864$-930,203$-1,194,274$-1,894,144$-3,395,123$-9,087,408$-4,086,797$-3,425,819$-4,176,940
    EBIT$-3,214,231$-3,645,327$-934,787$-638,864$-930,203$-1,194,274$-1,895,481$-3,430,440$-9,099,701$-4,094,116$-3,433,137$-4,184,259
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ENTO

    News

    No news available

    Company news will appear here when available

    ENTO Valuation and Fair Value

    P/B
    1.0x
    See GNG's fair value

    ENTO Competitors

    CompanyTicker
    Vyne Therapeutics IncVYNE
    SeaStar Medical Holding CorporationICU
    Quoin Pharmaceuticals Ltd DRCQNRX
    Modular Medical IncMODD
    Scilex Holding CompanySCLX
    Akari Therapeutics PLCAKTX
    Cocrystal Pharma IncCOCP
    Sensei Biotherapeutics IncSNSE

    Sector: Healthcare

    ENTO Bull Case vs Bear Case

    Bear case

    • ENTO beat EPS estimates in 37.5% of its last 8 reported quarters.

    ENTO Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -11.9%

    Frequently Asked Questions About ENTO

    Does ENTO pay dividends?

    Entero Therapeutics, Inc. (ENTO) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In